Buspar
Utilized to alleviate symptoms of generalized anxiety, this anxiolytic agent is designed to support mood regulation without significant sedative side effects.
- Category
- Mental Health
- Active ingredient
- Buspirone
- Supply
- Rx
- Route
- Oral use
- Form
- Tablet
- Strengths
- 5 · 10mg
Buspar details
- Condition
- Generalized Anxiety Disorder
- Therapeutic class
- Anxiolytic
- Pharmacological class
- Azaspirodecanedione
- Known off-label uses
- major depressive disorder
- Minor side effects
- dizziness; headache; nausea; lightheadedness
- Moderate side effects
- insomnia; nervousness; excitement
- Serious side effects
- serotonin syndrome, requires immediate medical attention
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription only (specially controlled medicine)
- Manufacturer
- Bristol-Myers Squibb
- Onset Time
- 1–2 weeks
- Duration
- 4–6 months
- Storage instructions
- Store below 25°C; keep out of direct light.
- Drug interactions
- grapefruit; maoi inhibitors; cns depressants
- Age restrictions
- Not for children under 18 years.
Contraindications
hypersensitivity to buspirone; severe renal impairment; severe hepatic impairment; epilepsy
Precautions and warnings
may impair driving ability; avoid alcohol during treatment; use with caution in elderly patients
Patient summary
Utilized to alleviate symptoms of generalized anxiety, this anxiolytic agent is designed to support mood regulation without significant sedative side effects.
Mechanism of action
Buspirone is a selective serotonin receptor agonist that acts on 5-HT1A receptors. It influences neurotransmitter pathways to help mitigate anxiety without the typical sedative or muscle-relaxant properties of benzodiazepines.
Pregnancy and breastfeeding
Pregnancy: Use only if necessary. Breastfeeding: Caution advised as excretion into milk is unknown.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Buspar
Buspar is the established brand name for Buspirone, a medication used for the management of Generalized Anxiety Disorder. Originally developed by Bristol-Myers Squibb, the medication is supplied as a tablet in strengths of 5mg and 10mg, providing a consistent option for individuals requiring this specific clinical treatment.
Buspar availability in Asia
Buspar is registered across 12 markets including Indonesia, Taiwan and South Korea, with availability also in the UAE, Singapore and Hong Kong. Generic Buspirone, often sourced from India, provides a more affordable alternative for expats and residents living far from local support. Availability varies throughout these regions, and the medication is best used under a doctor’s care for the management of chronic conditions.